Related Experiment Video
Updated: Aug 19, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Leptin profile in neonatal gonadotropin surge and relationship between leptin and body mass index in early infancy
Sema Akcurin1, Sevtap Velipasaoglu, Gayaz Akcurin
1Department of Paediatrics, Akdeniz University Medical School, Antalya, Turkey.
Insights
Leptin levels increase in infants during the first three months, but do not correlate with sex hormones during neonatal minipuberty. This suggests leptin may support infant growth rather than influencing early hormonal surges.
Area of Science:
- Pediatric Endocrinology
- Neonatal Physiology
- Hormone Regulation
Background:
- Neonatal 'minipuberty' involves dynamic hormonal changes.
- Leptin, a key metabolic hormone, plays a role in regulating body weight.
- The interplay between leptin, sex hormones, and growth in early infancy is not fully understood.
Purpose of the Study:
- To investigate the longitudinal profile of leptin during neonatal minipuberty.
- To examine the relationship between leptin and key sex hormones (LH, FSH, E2, TTE).
- To assess leptin's effect on body weight gain and BMI in the first three months of life.
Main Methods:
- A longitudinal study of 15 male and 15 female term infants.
- Serum leptin, LH, FSH, estradiol, and testosterone levels measured on days 3, 15, 30, and 90.
- Anthropometric measurements and BMI recorded at each time point.
Main Results:
- Leptin levels and BMI significantly increased in both sexes from day 3 to day 90.
- No significant sex differences were observed in leptin levels or leptin/BMI ratios.
- Leptin levels correlated with BMI on days 30 and 90, but not with LH, FSH, E2, or TTE.
Conclusions:
- Leptin levels are similar between sexes in early infancy and do not appear to influence neonatal minipuberty's hormonal surge.
- The lack of early correlation between leptin and BMI may indicate adaptive leptin resistance supporting infant catch-up growth.
Aim:
This study was designed to investigate the longitudinal and dynamic profile of leptin and its relationship with sex hormones including luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2) and testosterone (TTE) in neonatal 'minipuberty'. We also investigated the effects of leptin in the regulation of body weight gain and body mass index (BMI) in the first 3 months of life.
Methods:
A longitudinal study was carried out in a cohort of 15 male and 15 female term infants during the first 3 months of life. Blood samples were collected in the morning from the infants on the 3rd, 15th, 30th, and 90th days of life. At each sample collection, anthropometric measurements were recorded. Serum leptin, LH, FSH, E2 (girls only) and TTE (boys only) concentrations were analyzed using standard biochemical methods. Association of leptin with weight gain, BMI, and these hormones during infancy was evaluated.
Results:
Leptin levels increased significantly between the 3rd and 90th days of life in both boys and girls. BMI of both groups increased significantly from the 3rd to the 90th day. There was no significant difference in the leptin levels and leptin/BMI ratios of the two sexes at different time points. Leptin levels on the 30th and 90th days correlated significantly with BMI in both sexes. LH and FSH levels in both groups were found to be significantly higher on the 15th day of life. No correlation was observed between leptin and LH, FSH, E2 or TTE levels throughout the study.
Conclusions:
Leptin levels do not differ between the two sexes during early infancy and possibly there is no role for leptin in the surge of gonadotropins or sex steroids in neonatal minipuberty. The relationship between leptin and BMI could not be seen in the first postnatal days and the transient lack of the regulatory effect of BMI on leptin concentrations might reflect an adaptive resistance in the production of leptin to support catch-up growth after initial physiological weight loss in newborns.
More Related Videos
Related Concept Videos
Obesity
Pharmacokinetics in Pediatric Patients: Drug Distribution

